VISCHER AG and Baker McKenzie have advised Memo Therapeutics AG and its shareholders. Lenz & Staehelin, together with Bredin Prat, have represented Ipsen. Memo Therapeutics AG,...
Memo Therapeutics AG Sold to Ipsen in Transaction Centered on BK Polyomavirus Antibody
ARCHIMED Acquires Majority Stake in ExcellGene and Magellan Biologics & Consulting
Lenz & Staehelin has advised ARCHIMED. Walder Wyss has advised the sellers. ARCHIMED, a global private equity specialist in the healthcare sector, has acquired a majority...
Fire System SA Forms Strategic Partnership with Trajan Capital
Lenz & Staehelin has advised the shareholders of Fire System SA. Fire System SA, a leading Swiss provider of fire safety solutions, has entered into a...
SK Telecom’s Strategic Quantum Computing Partnership With IonQ
Lenz & Staehelin advised SK Telecom on all Swiss law aspects, along with lead counsel Lee&Ko and US law counsel White and Case. SK Telecom, a...
Unigestion’s Strategic Partnership With Kepler Cheuvreux
Lenz & Staehelin assisted Unigestion on all legal aspects of the process. Unigestion and Kepler Cheuvreux have entered into a strategic partnership to establish a joint...
Asceneuron SA’s $100 Million Series C Financing Round
Lenz & Staehelin advised Asceneuron in its Series C financing. Asceneuron SA, a clinical stage biotech company developing small molecules targeting tau protein aggregation, a root...
Volumina Medical’s $21 Million Series A Financing Round
Lenz & Staehelin has advised Volumina Medical in this financing round. Volumina Medical, a clinical stage MedTech company developing novel biomaterials for dermatology and plastic surgery,...
Transmutex’s CHF20 Million Series A Financing Round Extension
Lenz & Staehelin advised Transmutex on all legal matters. Transmutex SA, a nuclear engineering company based in Geneva, Switzerland, raised over CHF 20M in the extension...
Ferrer’s Progressive Supranuclear Palsy (PSP) License Agreement with Asceneuron
Lenz & Staehelin advised Asceneuron in this transaction. Spanish pharmaceutical company Ferrer and Swiss clinical stage biotechnology company Asceneuron have announced the signing of a licensing...
Gyrus Capital’s Acquisition of Consulcesi Group
Lenz & Staehelin advised Gyrus Capital in this transaction, alongside with Chiomenti (Italian law) and Wolf Theiss (Albanian law). Consulcesi and Falcon Industrial was advised by...
European Space Agency’s Partnership Agreement With European Broadcasting Union
Lenz & Staehelin has advised EBU on the deal. In June 2022, the European Space Agency (ESA) and the European Broadcasting Union (EBU) entered into an...
Beqom’s $300 Million Investment From Sumeru
Lenz & Staehelin advised beqom SA in this transaction, while Walkers and Weil, Gotshal & Manges LLP assisted Sumeru Equity Partners. beqom, a company sponsored inter...